Mortality patterns of SLE and the associated risk factors in Korean patients: a nationwide cohort study

被引:0
作者
Cho, Soo-Kyung [1 ,2 ]
Jeon, Yena [3 ]
Kim, Jung-hyo [4 ]
Jang, Eun Jin [4 ]
Jung, Sun-Young [5 ]
Sung, Yoon-Kyoung [1 ,2 ]
机构
[1] Hanyang Univ, Dept Rheumatol, Hosp Rheumat Dis, Seoul, South Korea
[2] Hanyang Univ, Inst Rheumatol Res, Seoul, South Korea
[3] Kyungpook Natl Univ, Dept Stat, Daegu, South Korea
[4] Andong Natl Univ, Dept Data Sci, Andong, South Korea
[5] Chung Ang Univ, Coll Pharm, Seoul, South Korea
来源
LUPUS SCIENCE & MEDICINE | 2025年 / 12卷 / 01期
基金
新加坡国家研究基金会;
关键词
Systemic Lupus Erythematosus; Mortality; Risk Factors; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ACUTE MYOCARDIAL-INFARCTION; DEATH; HYPERTENSION; POPULATION; DAMAGE;
D O I
10.1136/lupus-2024-001361
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background To evaluate the mortality patterns of SLE and the associated risk factors in Koreans.Methods Using the National Health Insurance database spanning 2008 to 2018, incident cases of SLE in patients aged 10-79 years were included. We analysed the all-cause mortality and cause-specific mortality, stratifying by sex and age. The mortality rate (MR) was calculated as the number of deaths per 100 000 person-years (PYs). The causes of death were identified by the International Classification of Diseases, 10th Revision codes during hospitalisation or emergency visit prior to death. A generalised estimating equation model was employed for risk factor analysis.Results In total, 11 375 incident SLE cases among patients with an average age of 42.3 +/- 16.7 years were recruited (86.1% female). During 57 658 PYs, 728 deaths occurred (MR 1262.62/100 000 PYs). The MR among men (2718.86/100 000 PYs) exceeded that among women (1060.57/100 000 PYs). The leading causes of death were SLE-related conditions (381.56/100 000 PYs), cardiovascular disease (CVD) (202.92/100 000 PYs), cancer (175.17/100 000 PYs) and infection (143.95/100 000 PYs). Of the SLE-related mortality, the key risk factors were pulmonary complications, such as pulmonary alveolar haemorrhage (OR 9.93), pulmonary arterial hypertension (OR 3.77) and interstitial lung disease (OR 3.27).Conclusions Among Korean patients with SLE, SLE-related conditions were the leading causes of mortality. However, CVD and cancer were also identified as the main causes of mortality. Furthermore, pulmonary manifestations were significantly associated with SLE-related mortality.
引用
收藏
页数:10
相关论文
共 38 条
  • [31] Urowitz M.B., Bookman A.A., Koehler B.E., Et al., The bimodal mortality pattern of systemic lupus erythematosus, Am J Med, 60, pp. 221-225, (1976)
  • [32] Hermansen M.-L., Lindhardsen J., Torp-Pedersen C., Et al., Incidence of Systemic Lupus Erythematosus and Lupus Nephritis in Denmark: A Nationwide Cohort Study, J Rheumatol, 43, pp. 1335-1339, (2016)
  • [33] Moss K.E., Ioannou Y., Sultan S.M., Et al., Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades, Ann Rheum Dis, 61, pp. 409-413, (2002)
  • [34] Sun Y., Zhou C., Zhao J., Et al., Systemic lupus erythematosus–associated diffuse alveolar hemorrhage: a single-center, matched case–control study in China, Lupus (Los Angel), 29, pp. 795-803, (2020)
  • [35] Prabu A., Patel K., Yee C.-S., Et al., Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus, Rheumatology (Oxford), 48, pp. 1506-1511, (2009)
  • [36] Kazzaz N.M., Coit P., Lewis E.E., Et al., Systemic lupus erythematosus complicated by diffuse alveolar haemorrhage: risk factors, therapy and survival, Lupus Sci Med, 2, (2015)
  • [37] Min H.K., Lee J.H., Jung S.M., Et al., Pulmonary hypertension in systemic lupus erythematosus: an independent predictor of patient survival, Korean J Intern Med, 30, pp. 232-241, (2015)
  • [38] Kandane-Rathnayake R., Golder V., Louthrenoo W., Et al., Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study, Lancet Rheumatol, 4, pp. e822-e830, (2022)